Question to the Department of Health and Social Care:
To ask Her Majesty's Government what steps they are taking to ensure that clinicians continue to have the right to prescribe any urinary incontinence product listed on Part IX of the Drug Tariff which they consider is the most appropriate for their patient.
Decisions about policy on the provision of medical products available from Part IX of the Drug Tariff, including urinary incontinence products, are a matter for local clinical commissioning groups and National Health Service trusts, taking account of the needs of their local populations and national guidance. Clinicians are expected to prescribe products that meet their patients’ clinical needs taking account of local commissioning policies as appropriate.
The Drug Tariff does not apply to NHS trusts who are responsible for selecting the products they wish to use locally.